13G Filing: Palo Alto Investors and Epizyme Inc. (NASDAQ:EPZM)

Page 6 of 8 – SEC Filing

Item 1.

(a) Name of Issuer

Epizyme, Inc.

(b) Address of Issuer’s Principal
Executive Offices

400 Technology Square, 4th Floor, Cambridge, MA 02139

Item 2.

(a) The names of the persons filing
this statement are:

Palo Alto Investors, LLC (“PAI”)
Palo Alto Healthcare Master Fund II, L.P.
Patrick Lee, MD
Anthony Joonkyoo Yun, MD

(collectively, the “Filers”).
(b) The principal business office of the Filers is located at:

470 University Avenue, Palo Alto, CA 94301



(c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer.
(d) This statement relates to shares of Common Stock of the Issuer (the “Stock”).

(e) The CUSIP number of the Issuer is: 29428V104

 

6

Follow Epizyme Inc. (NASDAQ:EPZM)